Cargando…
High Doses of Botulinum Toxin Type A for the Treatment of Post-Stroke Spasticity: Rationale for a Real Benefit for the Patients
In the past few years, there was a great interest in the use of higher doses of botulinum toxin type A, especially in case of upper and lower limb severe spasticity. To date, only one prospective, non-randomized, single-arm, multicenter, open-label, dose-titration study with the employment of incobo...
Autor principal: | Santamato, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145804/ https://www.ncbi.nlm.nih.gov/pubmed/35622579 http://dx.doi.org/10.3390/toxins14050332 |
Ejemplares similares
-
Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study
por: Picelli, Alessandro, et al.
Publicado: (2021) -
Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial
por: Kaji, Ryuji, et al.
Publicado: (2010) -
Does Botulinum Toxin Treatment Affect the Ultrasonographic Characteristics of Post-Stroke Spastic Equinus? A Retrospective Pilot Study
por: Picelli, Alessandro, et al.
Publicado: (2020) -
Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A: Clinical Implications from Ultrasonographic Evaluation
por: Battaglia, Marco, et al.
Publicado: (2021) -
Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity
por: Yazdchi, Mohammad, et al.
Publicado: (2013)